This message was sent to ##Email##
|
|
|
|
|
|
Register today for the 2016 Spring Forum being held April 21-22, 2016 at the Gaylord Palms in Orlando. Click here to visit the conference website.
HealthDay News via U.S. News & World Report
There appears to be a genetic basis for happiness levels in countries around the world, new research reports.
And a pleasant climate apparently helps, the findings suggested.
For the study, researchers analyzed data gathered by the World Values Survey between 2000 and 2014. The investigators found that people in countries that have the highest happiness ratings are more likely to have a specific version of a gene variant that boosts sensory pleasure and reduces pain.
READ MORE
FierceMedical Devices
The National Institutes of Health has launched a program to explore the role of genomics in common diseases such as heart disease, diabetes, stroke and autism. This program, along with the continuation of another program dedicated to the study of genomics underlying rare diseases like cystic fibrosis and muscular dystrophy, has gained a commitment for $313 million in NIH funding from various agencies over the next four years.
READ MORE
|
Promoted by
|
|
|
|
 |
News-Medical.net
Genetics play a key role in knee pain sensitivity, according to a team of researchers studying knee osteoarthritis patients.
"This work was part of a larger study focused on the daily lives of couples in which one person has arthritis," said Lynn Martire, professor of human development and family studies, Penn State. The researchers looked at how arthritis affects mood and interactions with each other.
READ MORE
| | BIOTECH/DIAGNOSTICS/PERSONALIZED MEDICINE |
Fox News
Ovarian cancer is one of the deadliest types of cancers because doctors lack effective early-diagnostic tools for the disease as well as treatment for the cancer once it progresses. But researchers at the University of Connecticut say the key to overcoming those hurdles may lie in personalized vaccines that rig an individual’s immune system to detect then destroy invading cancer cells.
READ MORE
Medical News Today
Scientists have devised a way to track the progress of chemotherapy at the cellular level as it travels to its target. The technique tags a fluorescent molecule onto the cancer drug and follows it in real time. In Nature Nanotechnology, researchers from Ohio State University in Columbus describe how they developed and tested the new technique on cancer cells in the lab using a common cancer drug. Plans for animal testing are already under way.
READ MORE
HealthCatalyst via PR Newswire
When President Barack Obama announced a $215 million precision medicine initiative in his State of the Union address one year ago, many observers predicted that healthcare would quickly jump on the bandwagon. Unlike the one-size-fits-all approach to medicine, precision medicine — often called "personalized medicine" — leverages advances in genomics and analysis of large data sets to personalize care and greatly accelerate medical research and drug discoveries.
READ MORE
News-Medical.net
Stem cells work throughout our lives as a sort of handyman, repairing damaged tissues and renewing some normal ones, like the skin we shed. Scientists have come to understand much about how stem cells function when we are adults, but less is known about where these stem cells come from to begin with, as an embryo is developing.
READ MORE
WebMD
Multiple sclerosis experts are welcoming a groundbreaking treatment that shows promise for some people with the disease. It uses harvested stem cells to reset patients’ immune systems and reverse some of the symptoms of MS.
An update on the treatment, developed at Sheffield Teaching Hospitals in the United Kingdom, was recently featured in a British television program. Cameras followed four people with the relapsing-remitting form of the disease as they got treated.
READ MORE
| | EMERGING MEDICAL TECHNOLOGIES |
MIT Technology Review
For the over 40 million people served by the more than 300 health systems working with startup CrossChx, checking in for a doctor’s appointment is much like unlocking an iPhone. All you need is your right index finger. Touch it onto a fingerprint reader at the check-in desk, and your identity is verified. Your driver’s license can stay in your wallet.
READ MORE
The Hill
Five years and $28.1 billion of federal dollars later, and the promise of better patient care and lower costs through electronic health records still hasn't come to fruition. Congress needs to take swift action to create a more accountable regulatory framework that gets electronic health records fully implemented and operating properly.
READ MORE
| | FDA: NEW TREATMENTS AND TECHNOLOGY |
Chicago Tribune
Since 2012, an increasing number of drugs have been approved by U.S. regulators through programs meant to speed them to market. It's good news for patients who benefit sooner from potentially life-saving treatments.
The downside, a government watchdog agency said, is that the Food and Drug Administration hasn't been keeping up with monitoring what happens after the drugs are being prescribed to patients — as it should.
READ MORE
NPR
A new method of delivering medication for opioid addicts gained approval from a Food and Drug Administration advisory panel this week. It's a matchstick-like insert designed to slip under the skin and release a drug over a period of months. Some physicians say the implant will be a useful addition to the currently short lineup of medication-assisted treatment options.
READ MORE
| | ACCOUNTABLE CARE ORGANIZATIONS |
HIT Consultant
Health Choice Preferred, a division of IASIS Healthcare, and Cigna have announced an accountable care collaboration designed to offer more than 16,000 Cigna commercial customers in Utah a more coordinated, personalized healthcare option.
The collaboration ties value-based incentives to performance improvements that support population health management and improve outcomes for Cigna’s customers.
READ MORE
Modern Healthcare
Hospitals and doctors have expressed a clear willingness to start their own Medicare Advantage plans. The latest iteration of Medicare's accountable care experiment paves the way for more of them to head in that direction.
That's not to say all health systems interested in managing population health will start applying for insurance licenses.
READ MORE
By Dr. Ebun O. Ebunlomo
 As we welcome each new year, we also anticipate remarks from the president during the annual State of the Union Address, which often outline our achievements as a nation in the past year and our focus for the new year. Ever wondered what the state of our nation's health is? Well, similar to the president's annual speech, we have an annual State of Public Health address by Dr. Tom Frieden, CDC Director, highlighting our greatest challenges and opportunities in 2016.
READ MORE
Bloomberg
America’s Health Insurance Plans is one of Washington’s most powerful lobby groups, spending millions of dollars a year to influence lawmakers, the White House and scores of state officials on the industry’s priorities.
Yet its latest fight isn’t in the halls of Congress, but inside its own headquarters. UnitedHealth Group Inc., the U.S.’s biggest health insurer, quit the group in June over a difference in strategy.
READ MORE
Forbes
All three Democrats vying for their party’s nomination have devoted a great deal of energy lamenting the purportedly unjust stagnation of worker wages in recent years. With equal vehemence they decry the unanimous posture of their Republican counterparts that Obamacare should be repealed and replaced as quickly as feasible. Indeed, in last night’s debate, Hillary Clinton brashly asserted that the Affordable Care Act “is one of the greatest accomplishments of President Obama, of the Democratic Party, and of our country.”
READ MORE
Fox News
An analysis by Freedom Partners shows Mississippi was the only state to see a drop in health insurance premiums on the individual marketplace in 2015.
The amount wasn’t much, minus 0.2 percent, but it was better than the other 49 states which all had increases under the Affordable Care Act, also known as Obamacare.
Mississippi Commissioner of Insurance Mike Chaney says the reason is simple: Competition and a previous medical loss ratio snafu.
READ MORE
|
| Seattle Genetics Demonstrates Commitment to Improve Hodgkin Lymphoma (HL) Treatment Paradigm Through ADCETRIS® Data Presentations at ASH 2015. Click here for more information.
|
Check out JMCM’s new website at www.jmcmpub.org
|
| Seattle Genetics Announces FDA Regular Approval of ADCETRIS® for Classical Hodgkin Lymphoma Patients at High Risk of Relapse or Progression. Click here to view more information. |
We wanted you to be aware that the FDA has granted accelerated approval of IBRANCE® (palbociclib) for the treatment of postmenopausal women with ER+/HER2- advanced breast cancer. Click here to see the press release!
|
| Sandoz, a Novartis company, announced today that Zarxio(TM) (filgrastim-sndz) is now available in the United States. Zarxio is the first biosimilar approved by the US Food and Drug Administration (FDA) and the first to launch in the US. Please click here for more information.
. |
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
 |
|
| We are an independent, objective clinical services company dedicated to providing solutions that focus on maximizing quality of care while limiting financial or regulatory risk.
|
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
